Penserra Capital Management »

Cara Therapeutics shares owned by Penserra Capital Management

Quarter-by-quarter ownership of Cara Therapeutics (CARA) shares owned by Penserra Capital Management from 13F filings

Historical chart of Penserra Capital Management investment in Cara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cara Therapeutics held by Penserra Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cara Therapeutics by Penserra Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $60k 82k 0.74
2023-09-30 $136k 82k 1.67
2023-06-30 $457k 162k 2.83
2023-03-31 $787k 160k 4.91
2022-12-31 $1.9M 177k 10.74
2022-09-30 $1.6M 174k 9.36
2022-06-30 $1.8M 199k 9.13
2022-03-31 $2.3M 189k 12.15
2021-12-31 $2.3M 191k 12.18
2021-09-30 $3.0M 194k 15.45
2021-06-30 $3.6M 249k 14.27
2021-03-31 $6.8M 312k 21.71
2020-12-31 $1.7M 114k 15.12
2020-09-30 $834k 66k 12.65
2020-06-30 $1.1M 66k 17.09
2020-03-31 $739k 56k 13.14
2019-12-31 $152k 9.4k 16.24
2019-09-30 $180k 9.9k 18.23